Population: Adolescents (12-17 years)

UNITY

Argentina Brazil Switzerland
|
2023-2026
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Adolescents (12-17 years)
  • Monkeypox virus
  • Mpox
  • Pharmacological intervention
  • Antivirals
  • Tecovirimat

Tibble

United Kingdom
|
2021-2022
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Infants (<1 year)
  • Adolescents (12-17 years)
  • Children (1-11 years)
  • Hospital
  • Outpatient clinic
  • Community
  • Non-hospital health centre
  • SARS-CoV-2
  • Acute COVID-19

POINTED-AD

Germany
|
2022-2023
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Infants (<1 year)
  • Adolescents (12-17 years)
  • Children (1-11 years)
  • SARS-CoV-2
  • Post COVID-19 condition

Mpox paediatric registry

Spain Mexico United States of America Congo (Democratic Republic of the)
|
2023
  • General population
  • Infants (<1 year)
  • Adolescents (12-17 years)
  • Children (1-11 years)
  • Hospital
  • Outpatient clinic
  • Monkeypox virus
  • Mpox

MEGA-Covid-19

Germany
|
2022
  • General population
  • Adolescents (12-17 years)
  • Children (1-11 years)
  • SARS-CoV-2
  • Post COVID-19 condition

LoTECA

Norway
|
2021-2022
  • Adults (18-64 years)
  • General population
  • Adolescents (12-17 years)
  • Hospital
  • Outpatient clinic
  • SARS-CoV-2
  • Post COVID-19 condition

LongCoCid

Germany
|
2022
  • General population
  • Adolescents (12-17 years)
  • Children (1-11 years)
  • Outpatient clinic
  • SARS-CoV-2
  • Post COVID-19 condition

Kuhn

Germany
|
2022
  • General population
  • Adolescents (12-17 years)
  • Non-hospital health centre
  • Telemedicine
  • SARS-CoV-2
  • Post COVID-19 condition

Kröger

Germany
|
2022-2022
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Adolescents (12-17 years)
  • Hospital
  • Outpatient clinic
  • Monkeypox virus
  • Mpox

Hedberg

Sweden
|
2020-2022
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Adolescents (12-17 years)
  • Children (1-11 years)
  • Hospital
  • Outpatient clinic
  • Primary care
  • SARS-CoV-2
  • Post COVID-19 condition

Drysdale

United Kingdom
|
2021-2022
  • Adults (18-64 years)
  • Elderly (≥65 years)
  • Fragile population
  • Adolescents (12-17 years)
  • Immunocompromised host
  • Outpatient clinic
  • Community
  • Non-hospital health centre
  • SARS-CoV-2
  • Acute COVID-19
  • Pharmacological intervention
  • Monoclonal antibodies
  • Sotrovimab

Dincher

Germany
|
2022
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Infants (<1 year)
  • Adolescents (12-17 years)
  • Children (1-11 years)
  • Outpatient clinic
  • SARS-CoV-2
  • Post COVID-19 condition
  • Non pharmacological intervention
  • Rehabilitation